Logo Logo

Chemistry and Pharmacy > Department of Pharmacy

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Creators | Item Type | Language | Volume
Jump to: 2079 | 2059 | 607 | 13 | 7
Number of items at this level: 6.

2079

Riedmayr, Lisa M. (2020): SMaRT for Therapeutic Purposes. In: Li, Hui; Elfman, Justin (eds.) : Chimeric RNA. Methods in molecular biology : Methods and Protocols, Vol. 2079. New York, NY: Springer Nature. pp. 219-232

2059

Kandil, Rima; Xie, Yuran; Mehta, Aditi; Merkel, Olivia (2020): A Method for Targeted Nonviral siRNA Delivery in Cancer and Inflammatory Diseases. In: Jain, Kewal K. (ed.) : Drug Delivery Systems. Methods in molecular biology, Vol. 2059. pp. 155-166

607

Roche, Aisling; Gentiluomo, Lorenzo; Sibanda, Nicole; Roessner, Dierk; Friess, Wolfgang; Trainoff, Steven P.; Curtis, Robin (2022): Towards an improved prediction of concentrated antibody solution viscosity using the Huggins coefficient. In: Journal of Colloid and Interface Science, Vol. 607, No. 2: pp. 1813-1824

13

Merkel, Olivia M. ORCID: 0000-0002-4151-3916; Mehta, Aditi (20. October 2020): Characterization techniques for studying the properties of nanocarriers for systemic delivery. In: Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications, Vol. 13. Cham: Springer. pp. 57-86 [PDF, 1MB]

7

Herrmann, Jennifer; Elnakady, Yasser A.; Wiedmann, Romina M.; Ullrich, Angelika; Rohde, Manfred; Kazmaier, Uli; Vollmar, Angelika M.; Müller, Rolf (2012): Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
In: PLOS ONE 7(5), e37416 [PDF, 1MB]

Kopp, Florian; Oak, Prajakta S.; Wagner, Ernst; Roidl, Andreas (2012): miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
In: PLOS ONE 7(11), e50469 [PDF, 700kB]

This list was generated on Sun Oct 2 07:32:33 2022 CEST.